GlassScriptPhysician profile
Luke Carlstrom
NPI 1477574127
$22,743.58
in general payments reported to CMS, 2019-2025
30 companies · $555 in 2025
The $555 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $371 · 2021: $341 · 2022: $20K · 2023: $980 · 2024: $273 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795 · Education: $13.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.97 |
| Education | $13.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,415.39 | 2022-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $759.57 | 2019-2025 | Nucala, Trelegy Ellipta |
| Inari Medical, INC. | $390.36 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $327.27 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $305.48 | 2020-2025 | Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.10 | 2019-2025 | Ofev, Jascayd |
| Livanova USA, INC. | $166.65 | 2023 | Lifesparc |
| Electromed, INC. | $128.55 | 2019-2024 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $114.19 | 2021-2025 | Dupixent |
| Abiomed | $109.49 | 2023 | Impella |
| Inspire Medical Systems, INC. | $81.22 | 2023-2025 | Inspire |
| Amgen INC. | $75.76 | 2022-2025 | Tezspire |
| Insmed, INC. | $70.01 | 2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $62.16 | 2019 | |
| Circassia INC. | $47.67 | 2025 | Niox |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $46.07 | 2019-2023 | Giapreza |
| Verona Pharma, INC. | $41.38 | 2025 | Ohtuvayre |
| Inogen, INC. | $39.54 | 2025 | |
| Ge Healthcare | $38.68 | 2020 | |
| Baxter Healthcare | $36.61 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $33.50 | 2024 | (Ak6) Vest Therapy |
| Mallinckrodt Enterprises LLC | $29.80 | 2019 | |
| Ambu INC. | $24.43 | 2023 | |
| Tactile Systems Technology INC | $22.98 | 2025 | Nimbl, Flexitouch Plus |
| Sunovion Pharmaceuticals INC. | $18.89 | 2019 | |
| United Therapeutics Corporation | $18.38 | 2021 | |
| Merck Sharp & Dohme LLC | $18.31 | 2019 | |
| Advanced Respiratory, INC | $15.90 | 2020 | |
| Shionogi INC | $13.20 | 2024 | Fetroja |
| Chiesi USA, INC. | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Carlstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.